Abstract

TREATMENT OF NON ALCOHOLIC FATTY LIVER DISEASE

Adarsh B.*, Sanjana Singh and Nikhil R.

.

Abstract

Introduction: Non-alcoholic fatty liver disease (NAFLD) is a very common disorder and refers to a group of conditions where excess fat accumulates in the liver of a person who drinks little or no alcohol. NAFLD is part of a metabolic syndrome characterized by diabetes, or pre- diabetes (insulin resistance), being overweight or obese, elevated blood lipids such as cholesterol and triglycerides, as well as high blood pressure. Methods: This was a prospective and longitudinal study in which 163 subjects were enrolled based on the inclusion and exclusion criteria from Sagar Hospitals. This study was assessed and evaluated by suitable statistical method. Results: In this study, the laboratory parameters of the subjects such as SGPT, SGOT, Fibroscan and USG were assessed to identify the underlying conditions and accordingly the treatment was initiated. From the obtained data, ursodeoxycholic acid was prescribed most frequently for treating NAFLD. By comparing the values of SGOT, SGPT and Weight, the effectiveness of treatment was determined. Conclusion: This study demonstrates that as people become older, their living patterns alter and more liver related problems develop. Additionally, comorbid disorders like HTN and DM are more common in males than in females. Thus, NAFLD is more common in males than in females. Pharmacotherapy and non-pharmacotherapy are used to improve the patient's state and avert further problems in the majority of NAFLD patients.

Keywords: Fatty liver, Fibroscan, SGOT, SGPT, USG.